Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$24.86 USD
+1.86 (8.09%)
Updated May 9, 2024 04:00 PM ET
After-Market: $24.63 -0.23 (-0.93%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.31 |
EPS Last Quarter | -1.06 |
Last EPS Surprise | 21.48% |
ABR | 1.54 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.57 |
Next Year | -5.51 |
EPS (TTM) | -5.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 19.96M | 12.66M | 50.48M | 73.33M |
# of Estimates | 10 | 8 | 12 | 10 |
High Estimate | 37.82M | 25.63M | 102.50M | 210.00M |
Low Estimate | 11.00M | 4.00M | 12.23M | 9.00M |
Year ago Sales | 13.59M | 11.99M | 36.28M | 50.48M |
Year over Year Growth Est. | 46.84% | 5.60% | 39.16% | 45.28% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.31 | -1.40 | -5.57 | -5.51 |
# of Estimates | 11 | 11 | 15 | 12 |
Most Recent Consensus | -1.37 | -1.10 | -5.41 | -4.93 |
High Estimate | -1.03 | -1.09 | -4.55 | -4.03 |
Low Estimate | -1.68 | -1.74 | -6.52 | -7.09 |
Year ago EPS | -1.40 | -1.38 | -5.42 | -5.57 |
Year over Year Growth Est. | 6.43% | -1.45% | -2.77% | 1.09% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.31 | -1.40 | -5.57 | -5.51 |
7 Days Ago | -1.31 | -1.40 | -5.57 | -5.51 |
30 Days Ago | -1.31 | -1.40 | -5.57 | -5.51 |
60 Days Ago | -1.31 | -1.42 | -5.56 | -5.52 |
90 Days Ago | -1.38 | -1.52 | -5.72 | -6.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.31 | -1.40 | -5.57 | -5.51 |
Zacks Consensus Estimate | -1.31 | -1.40 | -5.57 | -5.51 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.06 | -1.46 | -1.38 | -1.40 | NA |
Estimate | -1.35 | -1.47 | -1.52 | -1.32 | NA |
Difference | 0.29 | 0.01 | 0.14 | -0.08 | 0.09 |
Surprise | 21.48% | 0.68% | 9.21% | -6.06% | 6.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more